Tuesday, 04 Nov 2025

STAT+: Eli Lilly’s much-anticipated obesity pill yields modest results

Written by
STAT News
Published
Eli Lilly has hoped its candidate weight loss pill would safeguard its lead in the obesity market, but new results may prove disappointing.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago